Nano Drug Synthesis
Nano Drug Synthesis - Related Videos
01:29
Drugs Affecting Neurotransmitter Synthesis
0 Views •
2025
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
11:56
Fluorescence Imaging with One-nanometer Accuracy (FIONA)
0 Views •
Cited by 11 •
2014
Single fluorophores can be localized with nanometer precision using FIONA. Here a summary of the FIONA technique is reported, and how to carry out FIONA experiments is described.
08:33
Hydrogel Synthesis
0 Views •
2023
Source: Amber N. Barron, Ashlea Patterson, and Taylor D. Sparks, Department of Materials Science and Engineering, The University of Utah, Salt Lake City, UT Hydrogels are a versatile class of cross-linked polymers produced through relatively simple procedures and with generally inexpensive materials. They can be formed from solution and involve a polymer backbone formed from monomer reagents, an initiator which makes the polymer reactive and a crosslinking species which binds the polymer chains...
10:25
Sub-nanometer Resolution Imaging with Amplitude-modulation Atomic Force Microscopy in Liquid
0 Views •
Cited by 39 •
2016
We present a method for achieving sub-nanometer resolution images with amplitude-modulation (tapping mode) atomic force microscopy in liquid. The method is demonstrated on commercial atomic force microscopes. We explain the rationale behind our choices of parameters and suggest strategies for resolution optimization.
09:42
Solid Phase Synthesis
0 Views •
2023
Source: Vy M. Dong and Diane Le, Department of Chemistry, University of California, Irvine, CA Merrifield's solid-phase synthesis is a Nobel Prize winning invention where a reactant molecule is bound on a solid support and undergoes successive chemical reactions to form a desired compound. When the molecules are bound to a solid support, excess reagents and byproducts can be removed by washing away the impurities, while the target compound remains bound to the resin. Specifically, we will...
FAQs
Self-assembly allows drug-containing components to organize into nanoscale structures through interactions among the active compound, polymers, lipids, or inorganic materials. The resulting arrangement depends on the composition and surface properties of the components. Controlling these interactions helps researchers produce particles with characteristics suited to drug transport, stability, or controlled release rather than simply combining the ingredients without structural organization.
Solvent conditions, component concentration, temperature, and mixing influence how materials combine and when particles form. Changes in these variables can alter particle size, composition, and surface properties. In chemistry-based formulation work, systematic adjustment of these conditions helps researchers control the formation process and identify settings that produce a reproducible material with the desired drug-delivery characteristics.
Controlled precipitation forms particles by managing the conditions under which components come out of solution, whereas emulsification uses dispersed phases to combine materials during formulation. Both approaches require control of solvent conditions, concentration, temperature, and mixing, but they rely on different formation processes. Comparing these routes helps researchers select a preparation strategy appropriate for the materials and intended formulation properties.
A typical workflow begins by selecting the active compound and supporting materials, such as polymers, lipids, or inorganic components. Researchers then choose a formation approach, adjust solvent conditions, concentration, temperature, and mixing, and produce the drug-containing particles. Finally, they characterize size, structure, and composition to determine whether the formulation meets its intended performance and quality requirements.
Characterization connects the preparation conditions with the material that was produced. Measurements of particle size, structure, and composition show whether the formulation has the expected physical and chemical features. These results guide optimization by revealing how changes in synthesis or formulation affect the product, while also supporting quality assessment before researchers evaluate its usefulness for drug delivery.
These methods support delivery systems intended to improve drug solubility, stability, transport, or controlled release. Chemistry researchers can vary the particle components and preparation conditions, then relate those choices to measured size, structure, and composition. This approach provides a formulation-oriented way to investigate how nanoscale material properties influence the behavior and potential performance of a therapeutic system.